Intraoperative Molecular Imaging With Pafolacianine in Resection of Occult Pulmonary Malignancy in the ELUCIDATE Trial.

The classification of hiatal shapes and their use as a marker for complexity, operative interventions, and recurrence.

Thirty- and 90-Day Morbidity and Mortality by Clavien-Dindo after Surgery for Antireflux and Hiatal Hernia.

Single-cell chromatin accessibility reveals malignant regulatory programs in primary human cancers.

Morbidity and mortality after antireflux and hiatal hernia surgery across a spectrum of ages.

Molecular Tumor Board for Unicorns: Outcomes for rare and ultra-rare cancers using an N-of-One personalized treatment strategy.

The Milan score: A novel manometric tool for a more efficient diagnosis of gastro-esophageal reflux disease.

Tumor differentiation impacts response to neoadjuvant therapy and survival in patients with esophageal adenocarcinoma.

Serotonin-2 Receptor Agonists Produce Anti-inflammatory Effects through Functionally Selective Mechanisms That Involve the Suppression of Disease-Induced Arginase 1 Expression.

Pafolacianine for intraoperative molecular imaging of cancer in the lung: The ELUCIDATE trial.

Improving the Diagnostic Yield of High-Resolution Esophageal Manometry for GERD: The "Straight Leg-Raise" International Study.

Evolution in the treatment of gastroesophageal reflux disease over the last century: from a crural-centered to a lower esophageal sphincter-centered approach and back.

Commentary: The next step forward for enhanced recovery after surgery: Postdischarge benefits.

High-Risk Features of Esophageal Adenocarcinoma Following Neoadjuvant Chemoradiation: Patients for Whom Surgery Should Not Be Delayed.

Discussion.